Cargando…
Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study
OBJECTIVE: Apoptosis is increased in sepsis. Cytokeratin 18 (CK-18), a protein of the intermediate filament group present in most epithelial and parenchymal cells, is cleaved by the action of caspases and released into the blood as caspase-cleaved CK (CCCK)-18 during apoptosis. Circulating levels of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188625/ https://www.ncbi.nlm.nih.gov/pubmed/25290885 http://dx.doi.org/10.1371/journal.pone.0109618 |
_version_ | 1782338260209500160 |
---|---|
author | Lorente, Leonardo Martín, María M. González-Rivero, Agustín F. Ferreres, José Solé-Violán, Jordi Labarta, Lorenzo Díaz, César Jiménez, Alejandro Borreguero-León, Juan M. |
author_facet | Lorente, Leonardo Martín, María M. González-Rivero, Agustín F. Ferreres, José Solé-Violán, Jordi Labarta, Lorenzo Díaz, César Jiménez, Alejandro Borreguero-León, Juan M. |
author_sort | Lorente, Leonardo |
collection | PubMed |
description | OBJECTIVE: Apoptosis is increased in sepsis. Cytokeratin 18 (CK-18), a protein of the intermediate filament group present in most epithelial and parenchymal cells, is cleaved by the action of caspases and released into the blood as caspase-cleaved CK (CCCK)-18 during apoptosis. Circulating levels of CCCK-18 have scarcely been explored in septic patients. In one study with 101 severe septic patients, the authors reported higher serum CCCK-18 levels in non-survivors than in survivors; however, the sample size was too small to demonstrate an association between serum CCCK-18 levels and early mortality and whether they could be used as a biomarker to predict outcomes in septic patients. Thus, these were the objectives of this study with a large series of patients. METHODS: We performed a prospective, multicenter, observational study in six Spanish Intensive Care Units with 224 severe septic patients. Blood samples were collected at the time that severe sepsis was diagnosed to determine serum levels of CCCK-18, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6 and IL-10. The end point was 30-day mortality. RESULTS: Non-surviving patients (n = 80) showed higher serum CCCK-18 levels (P<0.001) than survivors (n = 144). Multiple logistic regression analysis showed that serum CCCK-18 levels>391 u/L were associated with 30-day survival (Odds ratio = 2.687; 95% confidence interval = 1.449–4.983; P = 0.002), controlling for SOFA score, serum lactic acid levels and age. Kaplan-Meier survival analysis showed that the risk of death in septic patients with serum CCCK-18 levels >391 u/L was higher than in patients with lower values (Hazard Ratio = 3.1; 95% CI = 1.96–4.84; P<0.001). Serum CCCK-18 levels were positively associated with serum levels of IL-6 and lactic acid, and with SOFA and APACHE scores. CONCLUSIONS: The major novel finding of our study, the largest cohort of septic patients providing data on circulating CCCK-18 levels, was that serum CCCK-18 levels are associated with mortality in severe septic patients. |
format | Online Article Text |
id | pubmed-4188625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41886252014-10-10 Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study Lorente, Leonardo Martín, María M. González-Rivero, Agustín F. Ferreres, José Solé-Violán, Jordi Labarta, Lorenzo Díaz, César Jiménez, Alejandro Borreguero-León, Juan M. PLoS One Research Article OBJECTIVE: Apoptosis is increased in sepsis. Cytokeratin 18 (CK-18), a protein of the intermediate filament group present in most epithelial and parenchymal cells, is cleaved by the action of caspases and released into the blood as caspase-cleaved CK (CCCK)-18 during apoptosis. Circulating levels of CCCK-18 have scarcely been explored in septic patients. In one study with 101 severe septic patients, the authors reported higher serum CCCK-18 levels in non-survivors than in survivors; however, the sample size was too small to demonstrate an association between serum CCCK-18 levels and early mortality and whether they could be used as a biomarker to predict outcomes in septic patients. Thus, these were the objectives of this study with a large series of patients. METHODS: We performed a prospective, multicenter, observational study in six Spanish Intensive Care Units with 224 severe septic patients. Blood samples were collected at the time that severe sepsis was diagnosed to determine serum levels of CCCK-18, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6 and IL-10. The end point was 30-day mortality. RESULTS: Non-surviving patients (n = 80) showed higher serum CCCK-18 levels (P<0.001) than survivors (n = 144). Multiple logistic regression analysis showed that serum CCCK-18 levels>391 u/L were associated with 30-day survival (Odds ratio = 2.687; 95% confidence interval = 1.449–4.983; P = 0.002), controlling for SOFA score, serum lactic acid levels and age. Kaplan-Meier survival analysis showed that the risk of death in septic patients with serum CCCK-18 levels >391 u/L was higher than in patients with lower values (Hazard Ratio = 3.1; 95% CI = 1.96–4.84; P<0.001). Serum CCCK-18 levels were positively associated with serum levels of IL-6 and lactic acid, and with SOFA and APACHE scores. CONCLUSIONS: The major novel finding of our study, the largest cohort of septic patients providing data on circulating CCCK-18 levels, was that serum CCCK-18 levels are associated with mortality in severe septic patients. Public Library of Science 2014-10-07 /pmc/articles/PMC4188625/ /pubmed/25290885 http://dx.doi.org/10.1371/journal.pone.0109618 Text en © 2014 Lorente et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Lorente, Leonardo Martín, María M. González-Rivero, Agustín F. Ferreres, José Solé-Violán, Jordi Labarta, Lorenzo Díaz, César Jiménez, Alejandro Borreguero-León, Juan M. Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study |
title | Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study |
title_full | Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study |
title_fullStr | Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study |
title_full_unstemmed | Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study |
title_short | Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study |
title_sort | serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188625/ https://www.ncbi.nlm.nih.gov/pubmed/25290885 http://dx.doi.org/10.1371/journal.pone.0109618 |
work_keys_str_mv | AT lorenteleonardo serumlevelsofcaspasecleavedcytokeratin18andmortalityareassociatedinseveresepticpatientspilotstudy AT martinmariam serumlevelsofcaspasecleavedcytokeratin18andmortalityareassociatedinseveresepticpatientspilotstudy AT gonzalezriveroagustinf serumlevelsofcaspasecleavedcytokeratin18andmortalityareassociatedinseveresepticpatientspilotstudy AT ferreresjose serumlevelsofcaspasecleavedcytokeratin18andmortalityareassociatedinseveresepticpatientspilotstudy AT soleviolanjordi serumlevelsofcaspasecleavedcytokeratin18andmortalityareassociatedinseveresepticpatientspilotstudy AT labartalorenzo serumlevelsofcaspasecleavedcytokeratin18andmortalityareassociatedinseveresepticpatientspilotstudy AT diazcesar serumlevelsofcaspasecleavedcytokeratin18andmortalityareassociatedinseveresepticpatientspilotstudy AT jimenezalejandro serumlevelsofcaspasecleavedcytokeratin18andmortalityareassociatedinseveresepticpatientspilotstudy AT borregueroleonjuanm serumlevelsofcaspasecleavedcytokeratin18andmortalityareassociatedinseveresepticpatientspilotstudy |